Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100

Baxter International Inc. (BAX) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Baxter International Inc. (BAX) trades at a P/B ratio of 2.1×. Over the past ten years it has ranged from 1.2× (November 2025) to 6.2× (April 2020); the current reading is higher than 13% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.6× (24.12%)
FY2024 2.1× (8.80%)
FY2023 2.3× (46.80%)
FY2022 4.4× (7.63%)
FY2021 4.7× 0.94%
FY2020 4.7× (12.99%)
FY2019 5.4× 20.39%
FY2018 4.5× 11.68%
FY2017 4.0× 36.53%
FY2016 2.9× 24.49%

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.8× 24.04%
Mar 2026 1.4× (10.48%)
Dec 2025 1.6× (0.97%)
Sep 2025 1.6× (23.83%)
42 more quarters

Against its own ten years

Low 1.2× High 6.2×
Ten-year median 3.6×
Current reading's percentile 14

P/B ratio against peers

Company P/B ratio
BLCO Bausch + Lomb Corporation compare 0.9×
COO The Cooper Companies, Inc. compare 1.3×
AVTR Avantor, Inc. compare 2.0×
BAX Baxter International Inc. 2.1×
ALGN Align Technology, Inc. compare 2.5×
ATR AptarGroup, Inc. compare 3.0×
SOLV Solventum Corporation compare 3.1×
RGEN Repligen Corporation compare 4.7×
WST West Pharmaceutical Services, Inc. compare 9.1×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on BAX